Loading...
EZZ Life Science Holdings Limited
EZZ.AX•ASX
Healthcare
Biotechnology
A$2.03
A$0.00(0.00%)
EZZ Life Science Holdings Limited (EZZ.AX) Financial Performance & Income Statement Overview
Review EZZ Life Science Holdings Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
78.88%
↑ 78.88%
Operating Income Growth
110.53%
↑ 110.53%
Net Income Growth
91.87%
↑ 91.87%
Operating Cash Flow Growth
53.05%
↑ 53.05%
Operating Margin
18.67%
↑ 18.67%
Gross Margin
77.36%
↑ 77.36%
Net Profit Margin
12.02%
↑ 12.02%
ROE
39.77%
↑ 39.77%
ROIC
57.40%
↑ 57.40%
EZZ Life Science Holdings Limited (EZZ.AX) Income Statement & Financial Overview
Review EZZ Life Science Holdings Limited's (EZZ.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $44.75M | $21.70M | $22.02M | $11.02M |
| Cost of Revenue | $10.01M | $7.14M | $5.34M | $2.32M |
| Gross Profit | $34.73M | $14.56M | $16.68M | $8.70M |
| Gross Profit Ratio | $0.78 | $0.67 | $0.76 | $0.79 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $26.51M | $13.06M | $13.82M | $6.73M |
| Operating Expenses | $26.51M | $13.06M | $13.82M | $7.14M |
| Total Costs & Expenses | $36.52M | $20.20M | $19.16M | $9.46M |
| Interest Income | $148808.00 | $46930.00 | $18398.00 | $5244.00 |
| Interest Expense | $10528.00 | $14226.00 | $7911.00 | $0.00 |
| Depreciation & Amortization | $200233.00 | $191304.00 | $123843.00 | $6230.00 |
| EBITDA | $8.64M | $1.73M | $3.25M | $1.45M |
| EBITDA Ratio | $0.19 | $0.08 | $0.14 | $0.13 |
| Operating Income | $8.22M | $1.49M | $2.86M | $1.45M |
| Operating Income Ratio | $0.18 | $0.07 | $0.13 | $0.13 |
| Other Income/Expenses (Net) | $209911.00 | $32704.00 | $260640.00 | $112820.00 |
| Income Before Tax | $8.43M | $1.53M | $3.12M | $1.56M |
| Income Before Tax Ratio | $0.19 | $0.07 | $0.14 | $0.14 |
| Income Tax Expense | $2.61M | $383724.00 | $791642.00 | $395821.00 |
| Net Income | $5.82M | $1.14M | $2.33M | $1.17M |
| Net Income Ratio | $0.13 | $0.05 | $0.11 | $0.11 |
| EPS | $0.13 | $0.03 | $0.05 | $0.03 |
| Diluted EPS | $0.13 | $0.03 | $0.05 | $0.03 |
| Weighted Avg Shares Outstanding | $43.46M | $42.70M | $42.70M | $42.66M |
| Weighted Avg Shares Outstanding (Diluted) | $43.46M | $42.70M | $42.70M | $42.65M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan